Results 101 to 110 of about 8,627 (176)
Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate
L Bellamy1, N Rosencher1, BI Eriksson21Anaesthesiology Department, Hôpital Cochin (AP-HP), René Descartes University, Paris 75014 France; 2Orthopaedic Department, University Hospital Sahlgrenska/Ostra, Gothenburg, SwedenAbstract: The
L Bellamy, N Rosencher, BI Eriksson
doaj
Fruquintinib, a highly selective, oral inhibitor of all three vascular endothelial growth factor receptors (−1, −2, and −3), is approved for previously treated metastatic colorectal cancer.
Martha Gonzalez +5 more
doaj +1 more source
Predicted effect of ticagrelor on the pharmacokinetics of dabigatran etexilate using physiologically based pharmacokinetic modeling. [PDF]
Wang N +6 more
europepmc +1 more source
An accurate, sensitive and rapid RP-HPLC method has been developed and validated for the estimation of Dabigatran etexilate mesylate from capsule Dosage form.
Patel, Bhavna +3 more
core
Primjena dabigatran-eteksilata u bolesnika koji boluju od nevalvularne atrijske fibrilacije u svrhu sprječavanja tromboembolijskih incidenata inicijalno je ohrabrena vrlo povoljnim rezultatima učinkovitosti i sigurnosti iz pivotalne kliničke studije RE ...
Počanić, Darko
core +1 more source
Moxifloxacin-Mediated Downregulation of Intestinal P-Glycoprotein Alters the Pharmacokinetics of Dabigatran Etexilate: Mechanistic Insights in Rats and PBPK Model-Informed Dose Optimization. [PDF]
Qu Y +8 more
europepmc +1 more source
A single-dose, four-cycle, fully repetitive crossover bioequivalence of dabigatran etexilate in Chinese. [PDF]
Yang Z +17 more
europepmc +1 more source
Dabigatran Etexilate Related Unilateral Adrenal Hemorrhage. [PDF]
Kalinov T +3 more
europepmc +1 more source

